Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)
China · Delayed Price · Currency is CNY 7.16
+0.10 (1.42%)
Aug 20, 2026, 3:04 PM CST
SHE:300636 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 119.28 | 252.84 | 176.38 | 512.75 | 141.96 | 161.29 |
Short-Term Investments | - | 515.12 | 194.58 | 64.49 | - | - |
Trading Asset Securities | 155.13 | 40.08 | 20.05 | - | - | - |
Cash & Short-Term Investments | 274.41 | 808.05 | 391.02 | 577.24 | 141.96 | 161.29 |
Cash Growth | -43.92% | 106.65% | -32.26% | 306.61% | -11.98% | -42.48% |
Accounts Receivable | 126.45 | 119.03 | 96.49 | 70.87 | 94.69 | 60.11 |
Other Receivables | 11.14 | 19.32 | 6.12 | 6.43 | 1.27 | 35.28 |
Receivables | 137.59 | 138.36 | 102.61 | 77.3 | 95.96 | 95.4 |
Inventory | 524.64 | 510.45 | 552.51 | 523.42 | 497.36 | 373.42 |
Prepaid Expenses | - | 0.21 | 0.32 | 0.54 | 2.28 | 0.01 |
Other Current Assets | 497.16 | 4.67 | 4.57 | 18.48 | 20.39 | 13.44 |
Total Current Assets | 1,434 | 1,462 | 1,051 | 1,197 | 757.95 | 643.56 |
Property, Plant & Equipment | 1,752 | 1,719 | 1,490 | 1,514 | 1,422 | 1,218 |
Long-Term Investments | 104.68 | 115.09 | 724.42 | 488.84 | - | - |
Other Intangible Assets | 18.55 | 18.75 | 19.28 | 20.17 | 21.08 | 21.43 |
Long-Term Deferred Tax Assets | 0.34 | 0.21 | 0.11 | 0.23 | 0.13 | 0.15 |
Long-Term Deferred Charges | 0.58 | 1 | - | - | - | - |
Other Long-Term Assets | 2.12 | 4.83 | 34.52 | 1.09 | 57.96 | 24.05 |
Total Assets | 3,312 | 3,321 | 3,320 | 3,221 | 2,259 | 1,907 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Accounts Payable | 183.88 | 179.12 | 150.36 | 130.39 | 212.82 | 143.78 |
Accrued Expenses | 17.14 | 32.27 | 31.36 | 24.8 | 21.13 | 17.84 |
Short-Term Debt | 171.34 | 194.43 | 300.8 | 429.31 | 267.83 | 182.29 |
Current Portion of Long-Term Debt | 401.71 | 253.84 | 1.31 | 86.55 | 16 | 4 |
Current Portion of Leases | - | 1.02 | 1.11 | 1.06 | 1.06 | 1.06 |
Current Income Taxes Payable | 1.73 | - | - | 0.03 | - | 0.05 |
Current Unearned Revenue | 4.14 | 3.31 | 4.24 | 2.09 | 11.69 | 10.03 |
Other Current Liabilities | 7.98 | 2.93 | 16.66 | 27.47 | 44.51 | 1.61 |
Total Current Liabilities | 787.92 | 666.92 | 505.84 | 701.71 | 575.04 | 360.67 |
Long-Term Debt | 38.85 | 187.1 | 398.5 | 250 | 326.33 | 619.63 |
Long-Term Leases | - | 0.12 | 1.03 | 2.04 | 2.91 | 3.79 |
Long-Term Unearned Revenue | 54.69 | 56.23 | 62.35 | 4.02 | 4.03 | 4.19 |
Long-Term Deferred Tax Liabilities | 46.14 | 45.44 | 43.08 | 37.22 | 30.88 | 30.34 |
Total Liabilities | 927.61 | 955.8 | 1,011 | 994.99 | 939.19 | 1,019 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Common Stock | 419.95 | 419.95 | 421.53 | 423.14 | 350.19 | 205.91 |
Additional Paid-In Capital | 1,241 | 1,241 | 1,252 | 1,271 | 543.38 | 251.54 |
Retained Earnings | 722.86 | 704.08 | 647.6 | 557.74 | 467.52 | 379.83 |
Treasury Stock | - | - | -12.34 | -25.18 | -41.42 | - |
Comprehensive Income & Other | - | - | - | - | - | 50.83 |
Shareholders' Equity | 2,384 | 2,365 | 2,309 | 2,226 | 1,320 | 888.11 |
Total Liabilities & Equity | 3,312 | 3,321 | 3,320 | 3,221 | 2,259 | 1,907 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Total Debt | 611.9 | 636.5 | 702.75 | 768.96 | 614.13 | 810.78 |
Net Cash (Debt) | -337.5 | 171.54 | -311.74 | -191.72 | -472.17 | -649.48 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.80 | 0.41 | -0.74 | -0.50 | -1.36 | -1.92 |
Filing Date Shares Outstanding | 419.95 | 419.95 | 420.12 | 420.58 | 346.66 | 308.86 |
Total Common Shares Outstanding | 419.95 | 419.95 | 420.12 | 420.58 | 346.66 | 308.86 |
Working Capital | 645.88 | 794.81 | 545.19 | 495.27 | 182.91 | 282.89 |
Book Value Per Share | 5.68 | 5.63 | 5.50 | 5.29 | 3.81 | 2.88 |
Tangible Book Value | 2,365 | 2,346 | 2,289 | 2,206 | 1,299 | 866.68 |
Tangible Book Value Per Share | 5.63 | 5.59 | 5.45 | 5.25 | 3.75 | 2.81 |
Buildings | - | 541.59 | 471.6 | 427.23 | 346.16 | 230.51 |
Machinery | - | 1,268 | 1,288 | 925.85 | 578.62 | 555.63 |
Construction In Progress | - | 460.26 | 186.23 | 503.08 | 772.97 | 641.34 |